Systematic analysis of gene properties influencing organ system phenotypes in mammalian perturbations

Bioinformatics

Volumn 30, Issue 21, 2014, Pages 3093-3100

  Vogt, Ingo ^a,b   Prinz, Jeanette ^a,b   Worf, Karolina ^c   Campillos, Monica ^a,b  

^a GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

ADVERSE DRUG REACTION; ANIMAL; ANTIBODY SPECIFICITY; DISEASES; GENE; GENE EXPRESSION; GENETICS; GENOTYPE; HUMAN; MOUSE; MUTATION; PHENOTYPE; PROTEIN ANALYSIS;

ANIMALS; DISEASE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GENE EXPRESSION; GENES; GENOTYPE; HUMANS; MICE; MUTATION; ORGAN SPECIFICITY; PHENOTYPE; PROTEIN INTERACTION MAPPING;

EID: 84911369913     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btu487     Document Type: Article

References (35)

1. Antonicelli, F. et al. (2009) Role of the elastin receptor complex (S-Gal/Cath-A/Neu- 1) in skin repair and regeneration. Wound Repair Regen., 17, 631-638.
2. Apweiler, R. et al. (2004) UniProt: the universal protein knowledgebase. Nucleic Acids Res., 32, D115-D119.
3. Azzaoui, K. et al. (2007) Modeling promiscuity based on in vitro safety pharmacology profiling data. ChemMedChem, 2, 874-880.
4. Bauer-Mehren, A. et al. (2010) DisGeNET: a Cytoscape plugin to visualize, integrate, search and analyze gene-disease networks. Bioinformatics, 26, 2924-2926.
5. Bauer-Mehren, A. et al. (2011) Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases. PloS One, 6, e20284.
6. Becker, K.G. et al. (2004) The genetic association database. Nat. Genet., 36, 431-432.
7. Blake, J.A. et al. (2009) The mouse genome database genotypes: phenotypes. Nucleic Acids Res., 37, D712-D719.
8. Campillos, M. et al. (2008) Drug target identification using side-effect similarity. Science, 321, 263-266.
9. Duca, L. et al. (2007) The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J. Biol. Chem., 282, 12484-12491.
10. Espinoza-Fonseca, L.M. (2006) The benefits of the multi-target approach in drug design and discovery. Bioorg. Med. Chem., 14, 896-897.
11. Georgi, B. et al. (2013) From mouse to human: evolutionary genomics analysis of human orthologs of essential genes. PLoS Genet., 9, e1003484.
12. Goh, K.-I. et al. (2007) The human disease network. Proc. Natl Acad. Sci. USA, 104, 8685-8690.
13. Hamosh, A. et al. (2005) Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res., 33, D514-D517.
14. Hillenmeyer, M.E. et al. (2008) The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science, 320, 362-365.
15. Hopkins, A.L. and Groom, C.R. (2002) The druggable genome. Nat. Rev. Drug Discov., 1, 727-730.
16. Hunter, D.J. (2005) Gene-environment interactions in human diseases. Nat. Rev. Genet., 6, 287-298.
17. Jeong, H. et al. (2001) Lethality and centrality in protein networks. Nature, 411, 41-42.
18. Keiser, M.J. et al. (2007) Relating protein pharmacology by ligand chemistry. Nat. Biotechnol., 25, 197-206.
19. Kuhn, M. et al. (2013) Systematic identification of proteins that elicit drug side effects. Mol. Syst. Biol., 9, 663.
20. Kuhn, M. et al. (2010a) A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol., 6, 343.
21. Kuhn, M. et al. (2010b) STITCH 2: an interaction network database for small molecules and proteins. Nucleic Acids Res., 38, D552-D556.
22. Liao, B.-Y. and Zhang, J. (2008) Null mutations in human and mouse orthologs frequently result in different phenotypes. Proc. Natl Acad. Sci. USA, 105, 6987-6992.
23. Mattingly, C.J. et al. (2006) The comparative toxicogenomics database: a cross-species resource for building chemical-gene interaction networks. Toxicol. Sci., 92, 587-595.
24. Mestres, J. et al. (2008) Data completeness-the Achilles heel of drug-target networks. Nat. Biotechnol., 26, 983-984.
25. Nichols, R.J. et al. (2011) Phenotypic landscape of a bacterial cell. Cell, 144, 143-156.
26. Pichler, W.J. et al. (2010) Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Med. Clin. North Am., 94, 645-664 xv.
27. Roth, B.L. et al. (2004)Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov., 3, 353-359.
28. Schug, J. et al. (2005) Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol., 6, R33.
29. Smith, C.L. et al. (2005) The mammalian phenotype ontology as a tool for annotating, analyzing and comparing phenotypic information. Genome Biol., 6, R7.
30. Su, A.I. et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl Acad. Sci. USA, 101, 6062-6067.
31. Visscher, P.M. et al. (2012) Five years of GWAS discovery. Am. J. Hum. Genet., 90, 7-24.
32. von Mering, C. et al. (2007) STRING 7-recent developments in the integration and prediction of protein interactions. Nucleic Acids Res., 35, D358-D362.
33. Wang, X. et al. (2013) Target essentiality and centrality characterize drug side effects. PLoS Comput. Biol., 9, e1003119.
34. White, J.K. et al. (2013) Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell, 154, 452-464.
35. Yu, H. et al. (2007) The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput. Biol., 3, e59.